Chondroprotection

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 85.29.183.66 (talk) at 13:53, 4 January 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

A chondroprotective compound is a specific compound or chemical that delays progressive joint space narrowing characteristic of arthritis and improves the biomechanics of articular joints by protecting chondrocytes.[1] These agents perform various functions, such as:

  1. Stimulating chondrocyte synthesis of collagen and proteoglycans
  2. Enhancing synoviocyte production of hyaluronan
  3. Inhibiting cartilage degradation
  4. Preventing fibrin formation in the vasculature

Chondroprotective agents can include both endogenous and synthetic chemicals. Endogenous molecules include hyaluronic acid, glucosamine, and chondroitin sulfate.

References

  1. ^ Felson, David T.; Kim, Young-Jo (2007). "The Futility of Current Approaches to Chondroprotection". Arthritis & Rheumatism. 56 (5): 1378–1383. doi:10.1002/art.22526.


Stub icon

This medical treatment–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Chondroprotection&oldid=818597256"